INVESTOR RELATIONS

Sensile Medical is a privately owned company. Its investor relations activities are primarily directed towards its current shareholders. A regular and ongoing information policy for its shareholders has been established.

Sensile Medical’s financing is primarily coming from private sources – individuals or organisations who believe in the potential of Sensile Medical’s people and technologies . Several public fundings such as CTI fundings are also included which validates the excellence of the technology innovations of Sensile Medical.

With a lean management structure and overhead, the funds raised to date can be used mainly to move Sensile Medical’s technology and product development forward and to establish beneficial collaborations.

Email: ir(at)sensile-medical.com